KENGREAL is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Cangrelor.
Product ID | 10122-620_17ff4f7d-5a56-4086-ad85-09918cce3dd0 |
NDC | 10122-620 |
Product Type | Human Prescription Drug |
Proprietary Name | KENGREAL |
Generic Name | Cangrelor |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2015-07-08 |
Marketing Category | NDA / NDA |
Application Number | NDA204958 |
Labeler Name | Chiesi USA, Inc. |
Substance Name | CANGRELOR |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-07-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204958 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-08 |
Marketing Category | NDA |
Application Number | NDA204958 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-08 |
Ingredient | Strength |
---|---|
CANGRELOR | 50 mg/1 |
SPL SET ID: | 88b434fa-8891-4fd5-9d86-7ea64667c08f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10122-620 | KENGREAL | cangrelor |
65293-003 | KENGREAL | cangrelor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KENGREAL 87442665 not registered Live/Pending |
Chiesi Farmaceutici S.P.A. 2017-05-09 |
KENGREAL 86166110 4867615 Live/Registered |
CHIESI FARMACEUTICI S.P.A. 2014-01-15 |